During a working visit to Kazakhstan by International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi a Roadmap was signed to deepen cooperation between IAEA and the Kazakhstan Atomic Energy Agency (KAEA) for the period until 2036. The document consolidates the long-term priorities of interaction between the two parties and creates a clear basis for the practical implementation of joint projects in key areas of the nuclear industry.
KAEA Chairman Almasadam Satkaliev said this was a logical continuation of agreements reached during the 69th session of the IAEA, “where our fundamental readiness to prepare and sign a Roadmap for deepening cooperation in the nuclear field was confirmed”. The roadmap “reflects the transition from general agreements to the systematic and practical implementation of joint priorities for the long term until 2036”.
During the visit, Grossi met with President Kassym-Jomart Tokayev to discuss Kazakhstan’s priorities in nuclear power, the peaceful uses of nuclear technology, Kazakhstan’s plans to advance its civilian nuclear power programme and broader geopolitical developments. Tokayev awarded Grossi the First-Degree Dostyk (Friendship) Order which symbolises the strong cooperation between Kazakhstan and the IAEA.
As well as the Roadmap, s separate agreement was signed between the IAEA and the National Academy of Sciences of Kazakhstan to strengthen cooperation in nuclear science and research. The arrangement will support knowledge exchange, joint research activities and scientific capacity building, including the use of the Sterile Insect Technique to help control agricultural pests and strengthen food security under the Atoms4Food initiative.
At the National Research Oncology Centre (NROC), Grossi signed a New Practical Arrangement between the IAEA and the centre. The agreement will enhance collaboration in radiation oncology, nuclear medicine, diagnostic imaging, medical physics, radiopharmacy and radiation safety in medicine. The partnership is expected to support training, improve access to modern technologies and strengthen national capabilities in diagnosing and treating cancer.
